Related Experiment Videos
Glutamine in pediatrics: where next?
1School of Pharmacy, Department of Clinical Pharmacy, University of Auckland, Building 504, 85 Park Road, Grafton, Auckland, New Zealand. p.ball@auckland.ac.nz
Insights
Further research is needed on glutamine supplementation in pediatric and neonatal care. Current evidence is limited, highlighting challenges in studying these vulnerable populations.
Area of Science:
- Pediatric Nutrition
- Neonatal Physiology
- Amino Acid Metabolism
Background:
- Glutamine is a conditionally essential amino acid with critical roles in cellular metabolism and immune function.
- Altered glutamine levels are observed in various pediatric and neonatal conditions, suggesting potential therapeutic relevance.
- Existing literature on glutamine use in pediatrics and neonatology is limited and often inconclusive.
Purpose of the Study:
- To review the existing literature on glutamine supplementation in pediatric and neonatal populations.
- To examine the challenges and issues associated with conducting research in these specific patient groups.
- To identify gaps in current knowledge and guide future research directions.
Main Methods:
- Comprehensive literature search using major biomedical databases (Medline, Embase, Current Contents, International Pharmaceutical Abstracts).
- Inclusion of data from bibliographic citations and personal communications to supplement published findings.
- Systematic review and synthesis of evidence regarding glutamine's effects and research methodologies.
Main Results:
- Evidence indicates that glutamine levels are influenced by various life stages and medical conditions in neonates and children.
- Emerging studies show potential utility, but many fail to demonstrate statistically significant differences in outcomes.
- Significant challenges inherent in pediatric and neonatal research, including ethical considerations and small sample sizes, were identified.
Conclusions:
- A substantial need for further rigorous research on glutamine in pediatrics and neonatology is evident.
- Larger, multicenter clinical trials are required to establish efficacy and safety.
- Standardized research protocols are necessary to overcome existing methodological limitations.
Objective:
We reviewed the literature and examined the issues surrounding the use of glutamine in pediatrics and neonatology.
Methods:
We reviewed the literature using Medline, Embase, Current Contents, and International Pharmaceutical Abstracts. Additional information was obtained from bibliographic citations and personal communications.
Results:
Evidence showed that glutamine levels are affected in a number of life stages and conditions. Useful, indicative studies are emerging but many fail to demonstrate significant differences. The problems of researching in this patient population were demonstrated.
Conclusion:
A need for a great deal of further research in this area, including larger multicenter trials, clearly emerged.